Logo-bi
Original Research
Nimgampalle Mallikarjuna, Kukkarasapalli Praveen, Kuna Yellamma*
Bioimpacts. 2016;6(4): 203-209. doi: 10.15171/bi.2016.27
PMCID: PMC5326668     PMID: 28265536     Scopus ID: 85013031898    
Editorial
Young M. Kwon* ORCID
BioImpacts. 2021;11(2): 85-86. doi: 10.34172/bi.2021.15
PMCID: PMC8022233     PMID: 33842278     Scopus ID: 85106598035    
Young M. Kwon received his Ph.D. from University of Utah (USA) and his postdoctoral training at University of Michigan (USA). He is currently an Associate Professor of Pharmaceutical Sciences at Nova Southeastern University College of Pharmacy (USA). Dr. Kwon’s research interests include targeted delivery and controlled release of biological molecules.
Original Research
Wael A. Mahdi ORCID, Mohammad S. Absar, Suna Choi, Victor C. Yang, Young M. Kwon* ORCID
BioImpacts. 2022;12(6): 479-486. doi: 10.34172/bi.2022.23477
PMCID: PMC9809136     PMID: 36644546     Scopus ID: 85143309781    
The tPA was successfully modified via enzymatic oxidation by GO, resulting in enhanced control of its activity in the prodrug construct. This approach can be applied to other therapeutic glycoproteins.


As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences. 
Acceptance rate: 24% 
Publication fee: Free of charge